Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Jul;8(Suppl 3):S287-S288.
doi: 10.21037/tau.2019.04.03.

Changes in testosterone prescribing patterns after FDA warning

Soum D Lokeshwar  1 , Joshua Bitran  1 , Ranjith Ramasamy  1
Affiliations
Editorial

Changes in testosterone prescribing patterns after FDA warning

Soum D Lokeshwar et al. Transl Androl Urol. 2019 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Dr. Ranjith Ramasamy: Coloplast—consultant; Boston Scientific—investigator; Endo—investigator, advisory board; Aytu Biosciences—investigator, advisory board; Direx—investigator. The other authors have no conflicts of interest to declare.

Comment on

References

    1. Baillargeon J, Urban RJ, Ottenbacher KJ, et al. Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med 2013;173:1465-6. 10.1001/jamainternmed.2013.6895 - DOI - PMC - PubMed
    1. Vigen R, O'Donnell CI, Barón AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 2013;310:1829-36. 10.1001/jama.2013.280386 - DOI - PubMed
    1. Finkle WD, Greenland S, Ridgeway GK, et al. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One 2014;9:e85805. 10.1371/journal.pone.0085805 - DOI - PMC - PubMed
    1. Seftel AD. Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke. J Urol 2015;194:759-60. - PubMed
    1. Shores MM, Matsumoto AM. Testosterone, aging and survival: biomarker or deficiency. Curr Opin Endocrinol Diabetes Obes 2014;21:209-16. 10.1097/MED.0000000000000057 - DOI - PMC - PubMed